Amyloid-β associated cortical thinning in clinically normal elderly. - Test2 - elhamkhani - TriplyDB

Amyloid-β associated cortical thinning in clinically normal elderly.

Amyloid-β associated cortical thinning in clinically normal elderly.

http://www.wikidata.org/entity/Q35053524

about

Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations "Is dopamine involved in Alzheimer's disease?"Testing the right target and right drug at the right stage Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease.A spectral graph regression model for learning brain connectivity of Alzheimer's disease Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging PET amyloid-beta imaging in preclinical Alzheimer's disease Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia.Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals Resting state functional connectivity in preclinical Alzheimer's disease Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.Responses of the Human Brain to Mild Dehydration and Rehydration Explored In Vivo by 1H-MR Imaging and Spectroscopy.Brain imaging of neurovascular dysfunction in Alzheimer's disease.The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis.Association of gray matter atrophy with age, β-amyloid, and cognition in aging Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition Structural imaging in early pre-states of dementia.Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.Failure to modulate attentional control in advanced aging linked to white matter pathology.Current status and future perspectives of magnetic resonance high-field imaging: a summary Session II: Mechanisms of age-related cognitive change and targets for intervention: neural circuits, networks, and plasticity.Should we disclose amyloid imaging results to cognitively normal individuals?Enrichment and stratification for predementia Alzheimer disease clinical trials.Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine.Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.The evolution of preclinical Alzheimer's disease: implications for prevention trials.Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.Cluster-based statistics for brain connectivity in correlation with behavioral measures.Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease

P2860

Q26765559-5B0FEC3F-9818-4C4C-AECC-F0EDF5034441 Q26830467-F1C86EE1-83AA-4DB1-AF98-3F017ACD100F Q26851680-A35CF5F5-068B-4B5E-8889-3824C32EDDF3 Q26864854-1A114049-8591-4CDF-8524-51AA99F8BB9B Q26995405-C34752E3-64BA-4B4E-A315-B47FBE448EF7 Q27009411-AA3AA39A-C673-4AFC-9914-73EBE6B39D4E Q28540060-555A7547-153F-48DF-B31F-EE09579E9104 Q28547622-711788F4-E87C-4B73-B129-D5C6A200A460 Q28705235-712037C9-3AE1-4951-B5DA-89BE9E7DEBAE Q28730725-12CF5D8C-F13F-4390-BDE1-AFEABD484069 Q30040695-3A028D9B-5EAA-4AE3-A8B8-A3967C9122DE Q30100986-82C67E6D-3EFE-4932-982F-753F4E6E6B97 Q30413904-E8B83B1B-A350-409F-AB94-F45F55BA56AE Q30417921-896FFBD3-845C-4A70-8971-A3DE36E96376 Q30531401-E0C82CC7-480A-47A3-830D-CF955CD74A7E Q30722226-A5477DCC-1055-4A03-A7A8-8E7FBE59CB73 Q30870223-60BB5129-10B2-4BC9-BB9E-F5871A718582 Q30994203-4CDAE753-4ECD-42CD-8D2B-1DB44BF07ACD Q31066988-7BD46534-0578-4D6B-BE63-8930F8B9456C Q33565271-0A607088-B9BF-44B8-A02E-6339593C0788 Q33582714-0424EA1D-2D83-46FF-8719-DCB1D025BA7E Q33699415-B2B823FB-AF12-4A2D-A05A-FE20A67BBA19 Q33872248-DBA5DD3F-0A98-4B60-9CE4-E28EF3BBD09F Q33882427-1B882D07-1D21-4EEC-83B5-8C2136BD80E6 Q33902744-FE2E3394-FC2E-48C6-BC68-FA090E9C7BCF Q33967561-7BEEC3CD-96A5-49FF-A82F-B2A227179B1D Q33998690-17926969-D831-4735-B8DB-68C0ED970C5A Q34201217-C43E92D6-C349-4FB3-89C5-6F11DC490459 Q34253039-6F47809E-5160-4511-A4A5-63B762D09025 Q34262812-29D94448-B8E5-45E4-9511-6932D6C518E6 Q34286140-FE445044-D6D1-4425-80A2-F9D6E6AC8EF9 Q34452239-3C1FA63A-43BA-4400-9614-B15B0A120BB0 Q34576144-AB8B535B-9EFF-4E21-AEA2-BD97323E49A9 Q34620948-003F378B-8244-492E-9DBC-4E8CA74357C0 Q34636863-3FBB6DA5-0DCB-415A-B160-97C9AA74F982 Q34717865-0F7EDBFC-A4E4-42D3-9BB1-5B1701868559 Q34849048-26EDAC9D-25E5-4D6E-A2BB-257B3BD9F21D Q34940642-84175CF5-E8E2-4DEC-9C5B-D62E44755A18 Q34973802-33DBC760-5EA8-428A-ABED-572CAB716AC0 Q35035669-BA2B6BF0-6BC4-49D7-BE93-48155EC2EB8C

P2860

Amyloid-β associated cortical thinning in clinically normal elderly.

http://www.wikidata.org/entity/Q35053524

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Amyloid-β associated cortical thinning in clinically normal elderly.

@ast

Amyloid-β associated cortical thinning in clinically normal elderly.

@en

type

label

Amyloid-β associated cortical thinning in clinically normal elderly.

@ast

Amyloid-β associated cortical thinning in clinically normal elderly.

@en

prefLabel

Amyloid-β associated cortical thinning in clinically normal elderly.

@ast

Amyloid-β associated cortical thinning in clinically normal elderly.

@en

P1433

Q35053524-653E910E-2272-4F6B-9BD1-AD77FD18263E

P1476

Q35053524-F5F24888-FF4C-4102-8035-93F353B4CDBF

P2093

Q35053524-07B5122F-552D-4496-BFC9-5BE297E1BF47

Q35053524-0840E657-847E-4E9A-88FC-9074F7CC2A4D

Q35053524-15D928DD-7142-4E4D-A5C0-E6B0BB251A7D

Q35053524-36BB23D5-8CF7-49AC-BF8C-16961C77586C

Q35053524-36D48978-C7DA-42E4-A433-174D0CD4F85C

Q35053524-435B3256-84A8-4E11-BB88-4D709871B41B

Q35053524-A203FA14-9FB8-4C43-B1F6-B60D3EA64EAE

Q35053524-B3F555C8-7001-4CB1-8B40-AA93585338B1

Q35053524-B9A934FC-0092-4B69-93F2-F5F7EC7691D2

Q35053524-CB446AFD-2148-49B4-A321-A3034F83283C

P2860

Q35053524-00B6FD1A-B947-413B-8E21-676AE58614CF

Q35053524-05150730-F6EA-4FEF-82DF-2F965249D2D2

Q35053524-061CA3C1-52A5-4725-B1B2-4D250FEE1B54

Q35053524-08FF6044-F19E-414C-A8E8-3F19C3D815E3

Q35053524-092BFC47-99DB-4830-B7AA-2812A1C3FFC0

Q35053524-09ADB6A2-74FC-41BD-BFDA-E73B95BCE382

Q35053524-0AEC1483-3EFD-43F5-8EA2-91AAD27D7FA6

Q35053524-0B17D6A9-C336-4963-A075-6FB7F97670CF

Q35053524-1066FE75-0F61-4899-855C-3E61B6C4A889

Q35053524-13C0B1BC-6DB1-4D09-9FCF-E472EE82CC09

P304

Q35053524-494958E9-C410-48E0-AF8F-CD75901EAED5

P31

Q35053524-13131DA8-CEB5-4BBB-92BC-B0EA2C31BBC7

P356

Q35053524-224B0A57-423E-4023-B4B1-B4896A11DA34

P433

Q35053524-70BBF06A-0EBA-4A63-8874-F2A252D6A41D

P478

Q35053524-1F43F672-3DFC-4287-8C31-870552EB6CD4

P50

Q35053524-436E334B-DEF7-4B04-8C31-78283E697CAF

Q35053524-B2C9468F-8AFF-4ADE-934B-F7B53BBD82D3

Q35053524-CFFC6AD9-ADBC-4813-8DA8-441767CA4B96

P577

Q35053524-B5EAB905-4FB8-4BD2-9B1C-DF78F18D7282

P5875

Q35053524-3220F9E0-4F86-4A95-8754-7C1EEC6F8689

P698

Q35053524-216D17EB-0EF5-4CFE-BA89-9A346D537830

P932

Q35053524-B6D9D8EF-2E41-4D57-824A-A241929DF3B0

P356

P1433

Annals of Neurology

P1476

Amyloid-β associated cortical thinning in clinically normal elderly.

@en

P2093

Deepti Putcha

http://www.w3.org/2001/XMLSchema#string

Donald Marks

http://www.w3.org/2001/XMLSchema#string

Dorene M Rentz

http://www.w3.org/2001/XMLSchema#string

Gad A Marshall

http://www.w3.org/2001/XMLSchema#string

J Alex Becker

http://www.w3.org/2001/XMLSchema#string

Jacqueline Maye

http://www.w3.org/2001/XMLSchema#string

Jeremy Carmasin

http://www.w3.org/2001/XMLSchema#string

Keith A Johnson

http://www.w3.org/2001/XMLSchema#string

Reisa A Sperling

http://www.w3.org/2001/XMLSchema#string

Stephen Salloway

http://www.w3.org/2001/XMLSchema#string

P2860

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease

Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function

The clinical use of structural MRI in Alzheimer disease

Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

P304

1032-1042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.22333

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Randy L. Buckner

Douglas N. Greve

P577

2011-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50852256

http://www.w3.org/2001/XMLSchema#string

P698

21437929

http://www.w3.org/2001/XMLSchema#string

P932

3117980

http://www.w3.org/2001/XMLSchema#string